You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API dabrafenib

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing dabrafenib

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Novartis Pharmaceuticals Corporation	TAFINLAR	dabrafenib	0078-0682	CELLULOSE, MICROCRYSTALLINE	2031-04-15
Novartis Pharmaceuticals Corporation	TAFINLAR	dabrafenib	0078-0682	FERRIC OXIDE RED	2031-04-15
Novartis Pharmaceuticals Corporation	TAFINLAR	dabrafenib	0078-0682	HYPROMELLOSES	2031-04-15
Novartis Pharmaceuticals Corporation	TAFINLAR	dabrafenib	0078-0682	MAGNESIUM STEARATE	2031-04-15
Novartis Pharmaceuticals Corporation	TAFINLAR	dabrafenib	0078-0682	SILICON DIOXIDE	2031-04-15
Novartis Pharmaceuticals Corporation	TAFINLAR	dabrafenib	0078-0682	TITANIUM DIOXIDE	2031-04-15
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for dabrafenib

Excipient focus: CELLULOSE, MICROCRYSTALLINE

dabrafenib drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	dabrafenib	0078-0682
>Company	>Ingredient	>NDC

dabrafenib drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE RED

dabrafenib drug variants containing FERRIC OXIDE RED

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	dabrafenib	0078-0682
>Company	>Ingredient	>NDC

dabrafenib drug variants not containing FERRIC OXIDE RED

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSES

dabrafenib drug variants containing HYPROMELLOSES

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	dabrafenib	0078-0682
>Company	>Ingredient	>NDC

dabrafenib drug variants not containing HYPROMELLOSES

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

dabrafenib drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	dabrafenib	0078-0682
>Company	>Ingredient	>NDC

dabrafenib drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SILICON DIOXIDE

dabrafenib drug variants containing SILICON DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	dabrafenib	0078-0682
>Company	>Ingredient	>NDC

dabrafenib drug variants not containing SILICON DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

dabrafenib drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	dabrafenib	0078-0682
>Company	>Ingredient	>NDC

dabrafenib drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.